Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call With Webcast
May 02 2017 - 4:01PM
Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company
developing ELAD®, a cell-based therapy targeting the treatment of
acute forms of liver failure, will release its first quarter 2017
financial results after the market closes on Tuesday, May 9, 2017.
The press release will be followed by a conference call on
Wednesday, May 10, 2017 at 4:30 p.m. ET, which will be open to the
public via telephone and webcast. During the conference call, the
Company will review financial results and discuss other business
matters.
The conference call dial-in numbers are (855)
765-5682 for domestic callers and (919) 825-3204 for international
callers. The conference ID number for the call is 14568675.
Participants may access the live webcast via a link on the Vital
Therapies website in the Investors Relations section under Events
at: http://ir.vitaltherapies.com/. The webcast will be archived on
the Company's website shortly after completion of the call.
For those unable to listen in at the designated
time, a conference call replay will be available for one week
following the conference call, from approximately 7:30 p.m. ET on
May 10, 2017 to 7:30 p.m. ET on May 17, 2017. The conference call
replay numbers for domestic and international callers are (855)
859-2056 and (404) 537-3406, respectively. The conference ID number
for the replay is 14568675.
About Vital Therapies, Inc.
Vital Therapies, Inc. is a biotherapeutic
company developing a cell-based therapy targeting the treatment of
acute forms of liver failure. The Company's ELAD System is an
extracorporeal human allogeneic cellular liver therapy currently in
phase 3 clinical trials. Vital Therapies, Inc. is based in San
Diego, California. Vital Therapies® and ELAD® are trademarks of
Vital Therapies, Inc.
Contact:
Vital Therapies, Inc.
Al Kildani
Vice President, Investor Relations and Business Development
858-673-6840
akildani@vitaltherapies.com
VITAL THERAPIES INC (NASDAQ:VTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
VITAL THERAPIES INC (NASDAQ:VTL)
Historical Stock Chart
From Apr 2023 to Apr 2024